These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 6230400

  • 1. Cutaneous leishmaniasis in anti-IgM-treated mice: enhanced resistance due to functional depletion of a B cell-dependent T cell involved in the suppressor pathway.
    Sacks DL, Scott PA, Asofsky R, Sher FA.
    J Immunol; 1984 Apr; 132(4):2072-7. PubMed ID: 6230400
    [Abstract] [Full Text] [Related]

  • 2. B lymphocytes are required for the generation of T cells that mediate healing of cutaneous leishmaniasis.
    Scott P, Natovitz P, Sher A.
    J Immunol; 1986 Aug 01; 137(3):1017-21. PubMed ID: 3487581
    [Abstract] [Full Text] [Related]

  • 3. B cell-deprived mice lack functional expression of certain T suppressor cell subsets.
    Flood PM, Janeway CA, Gershon RK.
    J Mol Cell Immunol; 1984 Aug 01; 1(3):167-76. PubMed ID: 6242856
    [Abstract] [Full Text] [Related]

  • 4. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY, Hale C, Howard JG.
    J Immunol; 1982 Apr 01; 128(4):1917-22. PubMed ID: 6120976
    [Abstract] [Full Text] [Related]

  • 5. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY, Singleton A, Cillari E, Howard JG.
    J Immunol; 1985 Sep 01; 135(3):2102-7. PubMed ID: 3160786
    [Abstract] [Full Text] [Related]

  • 6. T cell development in B cell deficient mice. III. Restriction specificity of suppressor T cell factor(s) produced in mice treated chronically with rabbit anti-mouse mu chain antibody.
    HayGlass KT, Naides SJ, Benacerraf B, Sy MS.
    J Mol Cell Immunol; 1985 Sep 01; 2(2):107-17. PubMed ID: 2978459
    [Abstract] [Full Text] [Related]

  • 7. Administration of monoclonal anti-IFN-gamma antibodies in vivo abrogates natural resistance of C3H/HeN mice to infection with Leishmania major.
    Belosevic M, Finbloom DS, Van Der Meide PH, Slayter MV, Nacy CA.
    J Immunol; 1989 Jul 01; 143(1):266-74. PubMed ID: 2499629
    [Abstract] [Full Text] [Related]

  • 8. The role of antigen-presenting B cells in T cell priming in vivo. Studies of B cell-deficient mice.
    Kurt-Jones EA, Liano D, HayGlass KA, Benacerraf B, Sy MS, Abbas AK.
    J Immunol; 1988 Jun 01; 140(11):3773-8. PubMed ID: 2453554
    [Abstract] [Full Text] [Related]

  • 9. Antibody-mediated allotype suppression in adult mice: the role of antigen, effector isotype and regulatory T cells.
    Curling EM, Dresser DW.
    Eur J Immunol; 1984 Oct 01; 14(10):865-70. PubMed ID: 6237917
    [Abstract] [Full Text] [Related]

  • 10. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY, Dhaliwal JS.
    J Immunol; 1987 Jun 15; 138(12):4450-6. PubMed ID: 3295049
    [Abstract] [Full Text] [Related]

  • 11. Immunobiological studies on experimental visceral leishmaniasis. II. Adherent cell-mediated down-regulation of delayed-type hypersensitivity response and up-regulation of B cell activation.
    Basak SK, Saha B, Bhattacharya A, Roy S.
    Eur J Immunol; 1992 Aug 15; 22(8):2041-5. PubMed ID: 1386313
    [Abstract] [Full Text] [Related]

  • 12. Effects of neonatal anti-delta antibody treatment on the murine immune system. I. Suppression of development of surface IgD+ B cells and expansion of a surface IgM+ IgD- B lymphocyte population.
    Finkelman FD, Mond JJ, Metcalf ES.
    J Immunol; 1983 Aug 15; 131(2):593-600. PubMed ID: 6602840
    [Abstract] [Full Text] [Related]

  • 13. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY, Howard JG, Hale C.
    J Immunol; 1984 Jan 15; 132(1):456-61. PubMed ID: 6228580
    [Abstract] [Full Text] [Related]

  • 14. Functional studies on B cell hybridomas with B cell surface antigens. II. Ia molecules on the cell membrane and the differentiative response to anti-mu antibody.
    Hamano T, Leiserson WM, Asofsky R.
    J Immunol; 1983 Jul 15; 131(1):98-102. PubMed ID: 6408183
    [Abstract] [Full Text] [Related]

  • 15. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H, Scollay R.
    Eur J Immunol; 1989 Feb 15; 19(2):307-14. PubMed ID: 2467816
    [Abstract] [Full Text] [Related]

  • 16. Cell-associated IgM, but not IgD or I-A/E, is important in the activation of suppressor T cells by antigen-primed B cells.
    Elkins KL, Stashak PW, Baker PJ.
    J Immunol; 1987 Aug 01; 139(3):695-701. PubMed ID: 2955049
    [Abstract] [Full Text] [Related]

  • 17. Defective induction of antigen-reactive proliferating T cells in B cell-deprived mice. II. Anti-mu treatment affects the initiation and recruitment of T cells.
    Ron Y, De Baetselier P, Tzehoval E, Gordon J, Feldman M, Segal S.
    Eur J Immunol; 1983 Feb 01; 13(2):167-71. PubMed ID: 6403358
    [Abstract] [Full Text] [Related]

  • 18. Selective elimination of a B cell subset having acceptor site(s) for T cell-replacing factor (TRF) with biotinylated antibody to the acceptor site(s) and avidin-ricin A-chain conjugate.
    Hashimoto N, Takatsu K, Masuho Y, Kishida K, Hara T, Hamaoka T.
    J Immunol; 1984 Jan 01; 132(1):129-35. PubMed ID: 6418795
    [Abstract] [Full Text] [Related]

  • 19. Functional studies on B cell hybridomas with B cell surface antigens. IV. Direct effects of cytochalasin B on differentiation.
    Hamano T, Asofsky R.
    J Immunol; 1984 Jan 01; 132(1):122-8. PubMed ID: 6418794
    [Abstract] [Full Text] [Related]

  • 20. Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1.
    George AJ, Tutt AL, Stevenson FK.
    J Immunol; 1987 Jan 15; 138(2):628-34. PubMed ID: 3491853
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.